RL

Rup Lata Devi

Active Director Director DIN 01799916
DIN 01799916 First appointment Jul 2003 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2003
Shareholding value •••• Premium profile

About Rup Lata Devi

Data last updated:

Rup Lata Devi is a Director at Zimalaya Drug Private Limited (since 2003). The company operates in Chemicals. Zimalaya Drug Private Limited reported revenue of ₹29 Lakh (FY 2024).

DIN 01799916
Primary Designation Director
Industry Chemicals
First Appointment 30 Jul 2003
Oldest Company Age 24 yrs
Largest company Zimalaya Drug Private Limited · ₹29 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zimalaya Drug Private Limited U24230BR2002PTC009875
Director30 Jul 20032002₹29 Lakh (FY 2024)Active

Board colleagues of Rup Lata Devi

NameDINCompanyDesignation
Brajesh Roy00913925Zimalaya Drug Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Zimalaya Drug Private Limited
Premium access

Shareholding and investment profile for Rup Lata Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rup Lata Devi

Rup Lata Devi currently holds 1 directorship: Zimalaya Drug Private Limited (Director, since 30 Jul 2003, revenue ₹29 Lakh (FY 2024)).

Rup Lata Devi was first appointed on 30 Jul 2003 as Director at Zimalaya Drug Private Limited.

The current boards of Rup Lata Devi's companies include Brajesh Roy (Zimalaya Drug Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available